Traduction de «granting ma for veterinary medicines » (Néerlandais → Français) :

Veterinary medicines The Veterinary Medicines unit ensures the quality, safety and efficacy of veterinary medicines in the interests of public health and animal welfare. This involves the following set of tasks: ●● Granting MA for veterinary medicines
Veterinary medicines The Veterinary Medicines unit ensures the quality, safety and efficacy of veterinary medicines in the interests of public health and animal welfare. This involves the following set of tasks: ●● Granting MA for veterinary medicines

It is also essential for rational and safe use of medicines that the information in advertising agrees with the elements approved of when the marketing authorisation (MA) for the medicine was granted. Healthcare professionals when making a therapeutic choice should not be influenced by elements that are not associated with the characteristics of the medicine.
It is also essential for rational and safe use of medicines that the information in advertising agrees with the elements approved of when the marketing authorisation (MA) for the medicine was granted. Healthcare professionals when making a therapeutic choice should not be influenced by elements that are not associated with the characteristics of the medicine.

Veterinary medicines Unit For the fifth year in a row the number of applications closed for obtaining marketing authorisation (MA) within the Veterinary medicines Unit has exceeded the number of new applications submitted.
Veterinary medicines Unit For the fifth year in a row the number of applications closed for obtaining marketing authorisation (MA) within the Veterinary medicines Unit has exceeded the number of new applications submitted.

The FAMHP intends to significantly increase its involvement in the lifecycle of immunological medicines for veterinary use by providing scientific advice, evaluating applications for clinical trials in Belgium, adopting (co-)rapporteurships for CP, MRP and DCP for MA of vaccines for veterinary use and developing pharmacovigilance and inspection activities.
The FAMHP intends to significantly increase its involvement in the lifecycle of immunological medicines for veterinary use by providing scientific advice, evaluating applications for clinical trials in Belgium, adopting (co-)rapporteurships for CP, MRP and DCP for MA of vaccines for veterinary use and developing pharmacovigilance and inspection activities.

The FAMHP’s Marketing authorisation Department is responsible for evaluating new applications and requests for amendments to existing marketing authorisation (MA) with a view to granting authorisation for marketing a medicine or health product.
The FAMHP’s Marketing authorisation Department is responsible for evaluating new applications and requests for amendments to existing marketing authorisation (MA) with a view to granting authorisation for marketing a medicine or health product.

The “POST pillar” embraces the activities which take place after granting the first MA for medicines and health products.
The “POST pillar” embraces the activities which take place after granting the first MA for medicines and health products.

The “PRE pillar” monitors the development of medicines and health products until the point when the initial marketing authorisation (MA) is granted.
The “PRE pillar” monitors the development of medicines and health products until the point when the initial marketing authorisation (MA) is granted.